SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing heavy selling, with widespread community sentiment labeling it a "rugpull" and "scam" amidst a significant market downturn. Many investors are openly criticizing its founder, Charles Hoskinson, and questioning ADA's long-term viability, suggesting a rotation into AI stocks or other cryptocurrencies. While some contrarian investors view current lows as a deep buying opportunity, the dominant discourse reflects strong bearish sentiment across the broader crypto market.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to overwhelming positive Phase 3 data for its ovarian cancer drug, relacorilant, which demonstrated improved survival and is touted as a potential new standard of care. This breakthrough has fueled speculation of a significant short squeeze, with community discussion highlighting the drug's blockbuster potential across cancer types and anticipating an upcoming regulatory decision for relacorilant in Cushing's syndrome. The strong pipeline progress is shifting the narrative around CORT as a leader in cortisol modulation, extending beyond its existing market to address major unmet medical needs.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is trending following a wave of bullish analyst upgrades and the growing market narrative around solar and energy storage's critical role in powering AI data centers. The community is actively discussing the company's strong virtual power plant strategy and consistent cash generation as key drivers. This momentum comes despite broader market volatility and seasonal concerns often associated with the residential solar sector.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is a focal point of intense community debate, with many users expressing frustration over recent price declines and fears of a 'Christmas dump' or 'rugpull' despite ongoing positive ETF inflows. While long-term holders emphasize patience and the asset's foundational utility for cross-border payments, others are actively predicting further significant drops and perceived market manipulation. The conversation is largely split between unwavering belief in a future surge and growing cynicism over its immediate prospects.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending following an acquisition offer from Kimberly-Clark, creating an arbitrage opportunity as its market price trades below the proposed deal value. The community is actively debating this valuation alongside persistent concerns around Tylenol-related litigation, which many dismiss as unsubstantiated, further influenced by recent significant insider buying.

East West Bancorp, Inc. is a bank holding company, which engages in the provision of financial services. It operates through the following business segments: Consumer and Business Banking, Commercial Banking, and Other. The Consumer and Business Banking segment provides financial service products and services to consumer and commercial customers through the company's branch network in the U.S. The Commercial Banking segment primarily focuses on commercial loans and deposits. The Other segment includes treasury activities of the company and elimination of inter-segment amounts. The company was founded on August 26, 1998 and is headquartered in Pasadena, CA.

East West Bancorp, Inc.

East West Bancorp is trending due to its consistent earnings beats, which have fueled numerous analyst upgrades and positive price target revisions. The community is actively discussing its strong long-term growth potential, especially as analysts anticipate a breakout year for the broader banking sector with favorable macro tailwinds. Despite some technical indicators suggesting overbought conditions, the prevailing sentiment remains bullish, highlighting its leadership among regional banks.

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Fulgent Genetics Inc

Fulgent Genetics is trending following a strategic acquisition of Bako Diagnostics assets and StrataDx, significantly expanding its pathology platform into higher-value services. This move, combined with stronger-than-expected earnings and a raised financial outlook, fuels community discussions about its substantial cash position. Investors are actively debating the company's long-term growth potential and management's strategy for unlocking value amidst perceived undervaluation.

Direxion Shares ETF Trust - Direxion Daily GOOGL Bear 1X Shares

Direxion Daily GOOGL Bear 1X Shares

Direxion Daily GOOGL Bear 1X Shares (GGLS) is actively trending as investors hotly debate Alphabet's recent market movements and upcoming financial reports. The community is buzzing with discussions about whether GOOGL's rally is sustainable, leading many to consider GGLS for potential bearish positions or hedging strategies against a perceived overextension.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is experiencing heightened investor interest driven by strong clinical trial data for its Galleri multi-cancer early detection test, coupled with strategic investments from global partners like Samsung. The community is keenly focused on the potential for future regulatory approvals and legislative efforts aimed at Medicare coverage, which could unlock substantial market penetration in the transformative field of early cancer diagnostics.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, Sunset, and Asset Closure. The Retail segment sells electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Sunset segment includes generation plants with announced retirement plans. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp. is generating significant investor debate following a recent dip below its 50-day SMA, with many viewing it as either a buying opportunity or a warning signal. Despite mixed Q3 results, bullish sentiment is fueled by increased share buybacks and an enhanced 2026 earnings outlook, underscoring its critical role in powering the booming AI data center infrastructure. The community is actively weighing Vistra's premium valuation against its robust clean energy portfolio and capital return strategy amid surging energy demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Purchase: CHIEF EXECUTIVE OFFICER of $BY Buys 4,040 Shares 
Read more on $BY: https://www.quiverquant.com/news/Insider+Purchase%3A+CHIEF+EXECUTIVE+OFFICER+of+%24BY+Buys+4%2C040+Shares

ROBERTO R HERENCIA, the CHIEF EXECUTIVE OFFICER of $BY, bought 4,040 shares of the company on 06-11-2025 for an estimated $99,990. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.3%.

Quiverquant

Insider Purchase: CHIEF EXECUTIVE OFFICER of $BY Buys 4,040 Shares | BY Stock News

StockTwits Web

Byline Bancorp Inc

Insider Purchase: CHIEF EXECUTIVE OFFICER of 